Applicant, as named in the Orange Book

Salerno Pharms

Next listed expiry: Flolipid on 23 Feb 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Flolipid · 2 strengths simvastatin	simvastatin	206679	23 Feb 2030	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.